|
⚲
|
| Keyboard |
| Rajavelu Esther
✚
|
|
|---|---|
| CIK # | 0001903716 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001903716] | |
| 4 | [0001903716] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Spero Therapeutics Inc | |
| Rajavelu Esther | |
| Fulcrum Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Spero Therapeutics Inc SPRO
Common Stock
|
2026-02-06 | Sell | 37,101 | $2.36 | 87,558 |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2026-02-06 | Sell | 50,816 | $2.36 | 119,926 |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2026-02-02 | Grant | 249,000 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 498,000 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2026-02-02 | Sell | 18,442 | $2.20 | 40,572 |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2025-11-07 | Sell | 40,270 | $2.37 | 95,440 |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2025-05-02 | Grant | 185,000 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2025-02-05 | Sell | 20,689 | $0.78 | 16,137 |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2025-02-03 | Grant | 266,139 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2025-02-03 | Grant | 100,000 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2024-11-08 | Sell | 17,245 | $1.30 | 22,418 |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2024-11-07 | Sell | 23,351 | $1.31 | 30,590 |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2024-02-01 | Grant | 119,866 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2023-11-13 | Grant | 300,000 | $0.00 | |
|
Fulcrum Therapeutics Inc FULC
Stock Option (right to buy) · derivative
|
2023-02-09 | Grant | 160,000 | $0.00 | |
|
Fulcrum Therapeutics Inc FULC
Stock Option (right to buy) · derivative
|
2022-01-03 | Grant | 200,000 | $0.00 |